Kenneth C Metchette

Title: Kenneth C Metchette: Innovator in Nucleic Acid Technologies

Introduction

Kenneth C Metchette is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of nucleic acid technologies, holding 2 patents that focus on innovative methods for nucleic acid amplification and treatment.

Latest Patents

His latest patents include "Methods for rendering amplified nucleic acid subsequently unamplifiable," which describes a method for treating nucleic acid to ensure it is unamplifiable after amplification. This process involves performing nucleic acid amplification in a reaction containing isopsoralen, followed by irradiation to render the amplified nucleic acid substantially unamplifiable. Another patent, "Activation compounds and methods of synthesis of activation compounds," focuses on isopsoralen compound compositions that can bind to nucleic acid polymers. The invention details the reaction conditions that activate these bound isopsoralens, resulting in covalent crosslinking to the nucleic acid polymers, thereby inhibiting their use as templates for enzymatic synthesis of complementary nucleic acid polymers.

Career Highlights

Throughout his career, Kenneth has demonstrated a commitment to advancing nucleic acid technologies. His work has implications for various applications in biotechnology and molecular biology.

Collaborations

Kenneth has collaborated with notable colleagues, including Stephen T Isaacs and John W Tessman, contributing to the advancement of their shared field.

Conclusion

Kenneth C Metchette's innovative work in nucleic acid technologies showcases his expertise and dedication to scientific advancement. His patents reflect significant progress in the field, paving the way for future developments.